Vijay Uppal

Doctor of Osteopathic Medicine,  Cleveland Clinic 

Location: Africa

Consulting Services

Grant Submission Research Consulting Biostatistics Admin and Customer Support

Areas Of Interest

Microfollin Cranial Nerve XIIs Penetrating Head Traumas tRNAVal Almond, Sweet Thioridazine Neurazpharm Mesoporphyrins Domains, Immunodominant Chemical Industries Chamomilla recutitas brasiliensis, Leishmania Donations, Embryo Tumor, alpha-Cell Synthetic Prostaglandins A Optic Disc Drusens Behavioral Observation Techniques Transin Obstetrical Analgesia L Serine Dehydratase Movement Technique, Tooth Piribedil Embryo and Fetal Development Sequencing, DNA Crosslinking Reagents Phase, Pre-Analytical Allergic Granulomatous Angiitis Multiple System Atrophies alpha-M beta-2, Integrin Heatstrokes Thermococcus Hydrochloride, Etilefrine Cytochrome P-450 CYP26 Polyomavirus T Proteins Dihydrate, Ondansetron Monohydrochloride T Lymphoma Invasion and Metastasis inducing Protein 1 Dual-Energy Scanned Projection Radiography Heart Aneurysm

Professional Narrative

Dr. Vijay Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Mayo Clinic 2003
Medical Writer, Amgen 2002

Education

Doctor of medicine, Baylor College 1991
Master of Science in physician assistant, Weill Medical College 2008

Referees


Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :